Literature DB >> 11001385

FR901228 causes mitotic arrest but does not alter microtubule polymerization.

V Sandor1, A R Robbins, R Robey, T Myers, E Sausville, S E Bates, D L Sackett.   

Abstract

FR901228, a natural cyclic depsipeptide, shows high cytotoxicity against human cancer cell lines (low nM IC50 values). Cells exposed to FR901228 arrest with G1 or G2/M DNA content; S phase is depleted. G2/M cells include cells arrested in mitosis. We wished to understand the mitotic arrest by this compound. Mitotic arrest is often due to interference with microtubules and COMPARE testing in the NCI drug screen indicated a possible taxane-like mechanism. Testing of FR901228 for tubulin binding or alteration of in vitro MT assembly failed to reveal any effect. Likewise, examination of cellular microtubules following exposure to FR901228 did not reveal any change. Similar G2/M accumulation was observed in MCF7, MCF10 and PC3 cells. About 50% of G2/M cells were mitotic and contained microtubule spindles. Mitotic cells peaked at about 14-16 h drug exposure and declined to near 0% by 24-30 h. The block was at prometaphase, with numerous chromosomes unattached to the spindle. We conclude that FR901228 induces formation of aberrant spindles probably by interfering with chromosome attachment, causing mitotic accumulation without affecting mitotic microtubules.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11001385     DOI: 10.1097/00001813-200007000-00005

Source DB:  PubMed          Journal:  Anticancer Drugs        ISSN: 0959-4973            Impact factor:   2.248


  10 in total

1.  A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity.

Authors:  Yun Li; Gary D Kao; Benjamin A Garcia; Jeffrey Shabanowitz; Donald F Hunt; Jun Qin; Caroline Phelan; Mitchell A Lazar
Journal:  Genes Dev       Date:  2006-09-15       Impact factor: 11.361

2.  Laboratory correlates for a phase II trial of romidepsin in cutaneous and peripheral T-cell lymphoma.

Authors:  Susan E Bates; Zhirong Zhan; Kenneth Steadman; Tomasz Obrzut; Victoria Luchenko; Robin Frye; Robert W Robey; Maria Turner; Erin R Gardner; William D Figg; Seth M Steinberg; Alex Ling; Tito Fojo; Kin Wah To; Richard L Piekarz
Journal:  Br J Haematol       Date:  2009-10-28       Impact factor: 6.998

3.  Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data.

Authors:  Susan E Bates; Robin Eisch; Alexander Ling; Douglas Rosing; Maria Turner; Stefania Pittaluga; H Miles Prince; Mark H Kirschbaum; Steven L Allen; Jasmine Zain; Larisa J Geskin; David Joske; Leslie Popplewell; Edward W Cowen; Elaine S Jaffe; Jean Nichols; Sally Kennedy; Seth M Steinberg; David J Liewehr; Louise C Showe; Caryn Steakley; John Wright; Tito Fojo; Thomas Litman; Richard L Piekarz
Journal:  Br J Haematol       Date:  2015-04-19       Impact factor: 6.998

4.  Characterization of a gene cluster responsible for the biosynthesis of anticancer agent FK228 in Chromobacterium violaceum No. 968.

Authors:  Yi-Qiang Cheng; Min Yang; Andrea M Matter
Journal:  Appl Environ Microbiol       Date:  2007-03-30       Impact factor: 4.792

5.  P-glycoprotein expression is induced in human pancreatic cancer xenografts during treatment with a cell cycle regulator, mimosine.

Authors:  Attila Zalatnai
Journal:  Pathol Oncol Res       Date:  2005-09-29       Impact factor: 3.201

6.  Preclinical studies of chemotherapy using histone deacetylase inhibitors in endometrial cancer.

Authors:  Noriyuki Takai; Hisashi Narahara
Journal:  Obstet Gynecol Int       Date:  2010-02-04

7.  Histone deacetylase 3 is required for centromeric H3K4 deacetylation and sister chromatid cohesion.

Authors:  Grégory Eot-Houllier; Géraldine Fulcrand; Yoshinori Watanabe; Laura Magnaghi-Jaulin; Christian Jaulin
Journal:  Genes Dev       Date:  2008-10-01       Impact factor: 11.361

8.  Histone deacetylase inhibitors influence chemotherapy transport by modulating expression and trafficking of a common polymorphic variant of the ABCG2 efflux transporter.

Authors:  Agnes Basseville; Akina Tamaki; Caterina Ierano; Shana Trostel; Yvona Ward; Robert W Robey; Ramanujan S Hegde; Susan E Bates
Journal:  Cancer Res       Date:  2012-04-03       Impact factor: 12.701

9.  Interpreting clinical assays for histone deacetylase inhibitors.

Authors:  Nadine Martinet; Philippe Bertrand
Journal:  Cancer Manag Res       Date:  2011-05-09       Impact factor: 3.989

10.  R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin.

Authors:  Maryam Safari; Thomas Litman; Robert W Robey; Andrés Aguilera; Arup R Chakraborty; William C Reinhold; Agnes Basseville; Lubov Petrukhin; Luigi Scotto; Owen A O'Connor; Yves Pommier; Antonio T Fojo; Susan E Bates
Journal:  Mol Cancer Res       Date:  2021-05-28       Impact factor: 6.333

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.